نتایج جستجو برای: sustained virology response svr

تعداد نتایج: 1047399  

Journal: :The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2006
Fernando Lopes Gonçales Aline Vigani Neiva Gonçales Antonio Alci Barone Evaldo Araújo Roberto Focaccia Umbeliana Oliveira Henrique Sérgio Morais Coelho Jacqueline Paixao Renata Perez Cirley Lobato Judith Weirich Heitor Rosa Andrelina Borges Ricardo Vila Maria Lúcia Corrêa-Giannella Maria Lúcia Gomes Ferraz

Combination therapy with pegylated interferon and ribavirin is considered the new standard therapy for naïve patients with chronic hepatitis C. We evaluated the efficacy and safety of treatment with weight-based peginterferon alpha-2b (1.5 mg/kg per week) plus ribavirin (800-1,200 mg/day) for 48 weeks in naïve, relapser and non-responder (to previous treatment with interferon plus ribavirin) pa...

Journal: :Journal of Ayub Medical College, Abbottabad : JAMC 2014
Mohammad Umar Hamamat-ul-Bushra Khaar Sameera Abbas Khan Masood Ahmed Saima Ambreen Zahid Mahmood Minhas Madeeha Nazar

BACKGROUND This study was conducted to assess the early predictability of virological response in chronic hepatitis-C patients (Genotype-3), treated with pegylated interferon alpha-2a and ribavirin with an objective of determining predictive values of Rapid Virological Response (RVR) and Early Virological Response (ETR) on Sustained Virological Response (SVR). METHOD This cross sectional stud...

Journal: :The Journal of infectious diseases 2014
Dennis J Hartigan-O'Connor Din Lin James C Ryan Valentina A Shvachko Myrna L Cozen Mark R Segal Norah A Terrault Lewis L Lanier M Michele Manos Joseph M McCune

BACKGROUND Interferon α (IFN-α) and ribavirin can induce a sustained virologic response (SVR) in some but not all hepatitis C virus (HCV)-infected patients. The mechanism of effective treatment is unclear. One possibility is that IFN-α differentially improves the functional capacity of classic myeloid dendritic cells (mDCs) by altering expression of surface molecules or cytokines. Others have p...

2011
Ioan Sporea Alina Popescu Manuela Curescu Roxana Sirli Isabel Dan Adrian Goldis Oana Gradinaru Melania Ardelean Mirela Danila Simona Bota Alexandra Deleanu

BACKGROUND Multiple variables influencing the sustained virologic response (SVR) in chronic hepatitis C have been evaluated. One of them is genetic polymorphism near the IL28B gene. OBJECTIVES The aim of this study was to evaluate the influence of IL28B genotypes on SVR rates in a group of patients with chronic hepatitis C from the western part of Romania. PATIENTS AND METHODS A retrospecti...

Journal: :Alimentary pharmacology & therapeutics 2009
G T Everson M L Shiffman J C Hoefs T R Morgan R K Sterling D A Wagner J L Desanto T M Curto E C Wright

BACKGROUND The impact of virologic response on hepatic function has not been previously defined. AIM To determine the relationships of quantitative liver function tests (QLFTs) with virological responses to peginterferon (PEG) +/- ribavirin (RBV) in patients with chronic hepatitis C and to use serial QLFTs to define the spectrum of hepatic improvement after sustained virological response (SVR...

2015
Fahmy T. Ali Mohamed A. M. Ali Mayada M. A. Elgizawy Ahmed M. Elsawy

BACKGROUND/AIMS The T-helper 1 (TH1) immune reaction is essential for the eradication of hepatitis C virus (HCV) during pegylated interferon α (PEG-IFN-α)- and ribavirin (RBV)-based therapy in chronic HCV patients. Secreted phosphoprotein 1 (SPP1) was shown to be a crucial cytokine for the initiation of a TH1 immune response. We aimed to investigate whether SPP1 single nucleotide polymorphisms ...

2015
Chen-Hua Liu Wang-Hui Sheng Hsin-Yun Sun Szu-Min Hsieh Yi-Chun Lo Chun-Jen Liu Tung-Hung Su Hung-Chih Yang Wen-Chun Liu Pei-Jer Chen Ding-Shinn Chen Chien-Ching Hung Jia-Horng Kao

Data are limited on the effectiveness and safety of peginterferon plus ribavirin in HIV-infected Asian patients with acute or chronic HCV infection. HIV-infected Taiwanese patients with acute HCV infection received peginterferon plus weight-based ribavirin for 24 weeks (n = 24), and those with chronic HCV genotype 1 or 6 (HCV-1/6) and HCV genotype 2 or 3 (HCV-2/3) infection received response-gu...

Journal: :journal of research in medical sciences 0
hamid kalantari associate professor, department of gastroenterology, school of medicine, isfahan university of medical sciences, isfahan, iran. neda rad resident of internal medicine, school of medicine, isfahan university of medical sciences, isfahan, iran.

background: the aim of this study was to evaluate the effectiveness of monotherapy with interferon alpha-2b and combination therapy with interferon alpha-2b plus ribavirin on chronic hepatitis c infection in thalassaemic patients. methods: in parallel group randomized, double blind, controlled trial, 32 thalassaemic patients with chronic hepatitis c infection completed the study. in a random fa...

Journal: :Acta medica Okayama 2015
Shintarou Nanba Fusao Ikeda Shin-Ichi Fujioka Yasuyuki Araki Kouichi Takaguchi Noriaki Hashimoto Hiroyuki Seki Akinobu Takaki Yoshiaki Iwasaki Kazuhide Yamamoto

The effectiveness of extending treatment duration as response guided therapy was previously reported for chronic hepatitis C (CHC) genotype 1, but is still controversial for genotype 2. The present study is a retrospective cohort study to investigate the effectiveness of extending treatment duration in therapy with pegylated interferon and ribavirin for patients with CHC genotype 2 by focusing ...

2016
Ming-Ying Lu Ching-I Huang Ming-Yen Hsieh Tusty-Juan Hsieh Edward Hsi Pei-Chien Tsai Yi-Shan Tsai Ching-Chih Lin Meng-Hsuan Hsieh Po-Cheng Liang Yi-Hung Lin Nai-Jen Hou Ming-Lun Yeh Chung-Feng Huang Zu-Yau Lin Shinn-Cherng Chen Jee-Fu Huang Wan-Long Chuang Chia-Yen Dai Ming-Lung Yu

Hepatitis C virus (HCV) can replicate in peripheral blood mononuclear cells (PBMCs), which can produce interferon to defend against virus infection. We hypothesized that dynamic gene expression in PBMCs might impact the treatment efficacy of peginterferon/ribavirin in HCV patients. PBMCs were collected at baseline, 1st week and 4th week of treatment from 27 chronic HCV-1 patients with 48-week p...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید